Form 4: IN8BIO Director Emily Fairbairn Acquires Stock Options

IN8BIO, Inc. reports that Director Emily Fairbairn acquired 22,000 stock options with an exercise price of $1.58, vesting over time.

Summary

• Director Emily Fairbairn has acquired 22,000 stock options in IN8BIO, Inc.
• The options have an exercise price of $1.58 per share.
• Vesting of the options will occur in monthly installments, starting June 9, 2026, with full vesting by the company's next annual meeting, contingent on continued service.
• The earliest transaction date reported is May 9, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard compensation and incentive mechanism for a director rather than a significant strategic or financial development.

Positives

• Director acquisition of stock options can signal confidence in the company's future prospects.
• The vesting schedule aligns with continued service, incentivizing long-term commitment from the director.

Risks

• The value of the stock options is subject to the future performance of IN8BIO, Inc.'s stock price.
• Continued service is a condition for vesting, implying potential forfeiture if service is terminated.

Future Outlook

The vesting schedule for the stock options indicates a forward-looking commitment tied to the company's performance and the director's continued service.

Industry Context

StockSavvy.ai notes that the acquisition of stock options by a director is a common practice in the biotechnology sector, often used as a long-term incentive to align management's interests with those of shareholders.

Stakeholder Impact

• Shareholders may view the director's acquisition of options positively, as it aligns her interests with long-term company performance.
• Employees may see this as a standard compensation practice for board members.

Next Steps

• The stock options will vest in monthly installments starting June 9, 2026.
• The options will be fully vested by the company's next annual meeting of stockholders, provided the Reporting Person continues to provide service.

Key Dates

Keywords

IN8BIO, Inc., INAB, Form 4, Stock Options, Director, Beneficial Ownership, Securities, Vesting Schedule